DK0991646T3 - Itraconazol med forbedret opløselighed, fremgangsmåde til fremstilling deraf, og et farmaceutisk præparat til oral administrering og indeholdende dette - Google Patents

Itraconazol med forbedret opløselighed, fremgangsmåde til fremstilling deraf, og et farmaceutisk præparat til oral administrering og indeholdende dette

Info

Publication number: DK0991646T3
Authority: DK; Denmark
Prior art keywords: itraconazole; preparation; pharmaceutical composition; oral administration; improved solubility
Prior art date: 1997-06-16

Application number

DK98929878T

Other languages

Danish (da)

English (en)

Inventor

Bong-Jin Cha

Jun-Gyo Oh

Su-Eon Kim

Original Assignee

Dong A Pharm Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-16

Filing date

1998-06-16

Publication date

2002-06-10

1998-06-16 Application filed by Dong A Pharm Co Ltd filed Critical Dong A Pharm Co Ltd

2002-06-10 Application granted granted Critical

2002-06-10 Publication of DK0991646T3 publication Critical patent/DK0991646T3/da

Links

VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 title abstract 3
229960004130 itraconazole Drugs 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title 1
229940079593 drug Drugs 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
238000004090 dissolution Methods 0.000 abstract 1
239000002245 particle Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Communicable Diseases (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

DK98929878T 1997-06-16 1998-06-16 Itraconazol med forbedret opløselighed, fremgangsmåde til fremstilling deraf, og et farmaceutisk præparat til oral administrering og indeholdende dette DK0991646T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR1019970024938A KR19990001564A (ko)	1997-06-16	1997-06-16	용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
PCT/KR1998/000164 WO1998057967A1 (fr)	1997-06-16	1998-06-16	Itraconazole possedant une meilleure solubilite, procede de preparation de ce dernier et composition pharmaceutique pour administration orale comprenant cet itraconazole

Publications (1)

Publication Number	Publication Date
DK0991646T3 true DK0991646T3 (da)	2002-06-10

Family

ID=19509733

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98929878T DK0991646T3 (da)	1997-06-16	1998-06-16	Itraconazol med forbedret opløselighed, fremgangsmåde til fremstilling deraf, og et farmaceutisk præparat til oral administrering og indeholdende dette

Country Status (17)

Country	Link
US (1)	US6346533B1 (fr)
EP (1)	EP0991646B1 (fr)
JP (1)	JP2002504930A (fr)
KR (1)	KR19990001564A (fr)
CN (1)	CN1129598C (fr)
AT (1)	ATE216699T1 (fr)
AU (1)	AU7939298A (fr)
BR (1)	BR9810124A (fr)
CA (1)	CA2294398A1 (fr)
DE (1)	DE69805070T2 (fr)
DK (1)	DK0991646T3 (fr)
ES (1)	ES2177022T3 (fr)
HU (1)	HUP0004050A3 (fr)
PL (1)	PL338631A1 (fr)
PT (1)	PT991646E (fr)
WO (1)	WO1998057967A1 (fr)
YU (1)	YU66799A (fr)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003531099A (ja)	1999-03-24	2003-10-21	エフエムシーコーポレーション	改良された水溶解度をもつ医薬製剤
IT1312115B1 (it) *	1999-06-24	2002-04-04	Nicox Sa	Composti amorfi e relative composizioni farmaceutiche
KR100694667B1 (ko) *	1999-12-08	2007-03-14	동아제약주식회사	생체내이용률 향상과 개인간 및 개인내 흡수 편차를감소시킨 이트라코나졸 함유 항진균성 제제
KR20010097244A (ko) *	2000-04-21	2001-11-08	유충식	위산도 비의존성 고용해도를 갖는 이트라코나졸 함유약학적 조성물 및 그 제조방법
KR100432949B1 (ko) *	2000-06-13	2004-05-31	코오롱제약주식회사	생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
US7193084B2 (en) *	2000-12-22	2007-03-20	Baxter International Inc.	Polymorphic form of itraconazole
US6951656B2 (en)	2000-12-22	2005-10-04	Baxter International Inc.	Microprecipitation method for preparing submicron suspensions
US20050048126A1 (en) *	2000-12-22	2005-03-03	Barrett Rabinow	Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
BR0116377A (pt) *	2000-12-22	2005-12-13	Baxter Int	Métodos para preparar partìculas submicronicamente dimensionadas de um composto orgânico, e para preparar uma suspensão de um composto farmaceuticamente ativo, e, composição de matéria
US6884436B2 (en) *	2000-12-22	2005-04-26	Baxter International Inc.	Method for preparing submicron particle suspensions
US20040256749A1 (en) *	2000-12-22	2004-12-23	Mahesh Chaubal	Process for production of essentially solvent-free small particles
US20030096013A1 (en) *	2000-12-22	2003-05-22	Jane Werling	Preparation of submicron sized particles with polymorph control
US6869617B2 (en)	2000-12-22	2005-03-22	Baxter International Inc.	Microprecipitation method for preparing submicron suspensions
US9700866B2 (en)	2000-12-22	2017-07-11	Baxter International Inc.	Surfactant systems for delivery of organic compounds
US8067032B2 (en)	2000-12-22	2011-11-29	Baxter International Inc.	Method for preparing submicron particles of antineoplastic agents
US6977085B2 (en)	2000-12-22	2005-12-20	Baxter International Inc.	Method for preparing submicron suspensions with polymorph control
US20040173147A1 (en) *	2001-06-07	2004-09-09	Figueroa Iddys D.	Application of a bioactive agent to a delivery substrate
US20040173146A1 (en) *	2001-06-07	2004-09-09	Figueroa Iddys D.	Application of a bioactive agent to a delivery substrate
US6962715B2 (en) *	2001-10-24	2005-11-08	Hewlett-Packard Development Company, L.P.	Method and dosage form for dispensing a bioactive substance
WO2002100407A1 (fr) *	2001-06-12	2002-12-19	Smartrix Technologies Inc.	Granules d'itraconazole: formulations pharmaceutiques pour administration orale et procede de preparation de ces dernieres
WO2003011254A1 (fr) *	2001-07-31	2003-02-13	Capricorn Pharma Inc.	Billes de medicament amorphe
KR100438485B1 (ko) *	2001-08-13	2004-07-09	한국디디에스제약 주식회사	아졸류 항진균제의 약제학적 조성물
US20060003012A9 (en)	2001-09-26	2006-01-05	Sean Brynjelsen	Preparation of submicron solid particle suspensions by sonication of multiphase systems
CN1558755A (zh)	2001-09-26	2004-12-29	��ع��ʹ�˾	通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
US7112340B2 (en) *	2001-10-19	2006-09-26	Baxter International Inc.	Compositions of and method for preparing stable particles in a frozen aqueous matrix
CA2363376A1 (fr) *	2001-11-16	2003-05-16	Bernard Charles Sherman	Compositions pharmaceutiques solides, comprenant de l'itraconazole, destinees a l'administration orale
US7446107B2 (en)	2002-02-15	2008-11-04	Transform Pharmaceuticals, Inc.	Crystalline forms of conazoles and methods of making and using the same
US7078526B2 (en)	2002-05-31	2006-07-18	Transform Pharmaceuticals, Inc.	CIS-itraconazole crystalline forms and related processes, pharmaceutical compositions and methods
US7790905B2 (en)	2002-02-15	2010-09-07	Mcneil-Ppc, Inc.	Pharmaceutical propylene glycol solvate compositions
WO2004000284A1 (fr)	2002-06-21	2003-12-31	Transform Pharmaceuticals, Inc.	Compositions pharmaceutiques a dissolution amelioree
US7927613B2 (en)	2002-02-15	2011-04-19	University Of South Florida	Pharmaceutical co-crystal compositions
IL163846A0 (en)	2002-03-01	2005-12-18	Univ South Florida	Multiple-component solid phases containing at least one active pharmaceutical ingredient
EP2085074A1 (fr)	2002-03-26	2009-08-05	Teva Pharmaceutical Industries Ltd.	Microparticules de médicament
KR100557680B1 (ko) *	2002-11-23	2006-03-07	한국유나이티드제약 주식회사	이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
US8183290B2 (en)	2002-12-30	2012-05-22	Mcneil-Ppc, Inc.	Pharmaceutically acceptable propylene glycol solvate of naproxen
SI1438960T2 (sl) *	2003-01-14	2013-04-30	Cimex Pharma Ag	Sestavek itrakonazola, dispergiranega v hidrofilnem polimeru, z izboljĹˇano biorazpoloĹľljivostjo
GB0319797D0 (en) *	2003-08-26	2003-09-24	Leuven K U Res & Dev	Particle size reduction of poorly soluble drugs
PT1663321E (pt) *	2003-09-22	2012-11-15	Baxter Int	Esterilização a alta pressão para esterilizar definitivamente preparações farmacêuticas e produtos médicos
US20050118265A1 (en) *	2003-11-28	2005-06-02	Anandi Krishnan	Antifungal oral dosage forms and the methods for preparation
US7618953B2 (en)	2004-02-26	2009-11-17	Zentiva, A.S.	Amorphous forms of risedronate monosodium
CN1294912C (zh) *	2004-03-01	2007-01-17	上海医药工业研究院	伊曲康唑盐酸盐组合物及其冻干粉针
US20050202051A1 (en) *	2004-03-15	2005-09-15	Chinea Vanessa I.	Pharmaceutical vehicle
US20050203482A1 (en) *	2004-03-15	2005-09-15	Chinea Vanessa I.	Pharmaceutical dispensing apparatus and method
US9504658B2 (en)	2004-11-09	2016-11-29	Board Of Regents, The University Of Texas System	Stabilized HME composition with small drug particles
US20060182777A1 (en) *	2005-02-15	2006-08-17	Steve Kangas	Method of modulating drug release from a coated substrate
EP1906973A2 (fr) *	2005-06-14	2008-04-09	Baxter International Inc.	Preparations pharmaceutiques permettant de reduire les interactions entre medicaments
US20070134341A1 (en) *	2005-11-15	2007-06-14	Kipp James E	Compositions of lipoxygenase inhibitors
US20090152176A1 (en) *	2006-12-23	2009-06-18	Baxter International Inc.	Magnetic separation of fine particles from compositions
US8722736B2 (en) *	2007-05-22	2014-05-13	Baxter International Inc.	Multi-dose concentrate esmolol with benzyl alcohol
US20080293814A1 (en) *	2007-05-22	2008-11-27	Deepak Tiwari	Concentrate esmolol
US8426467B2 (en) *	2007-05-22	2013-04-23	Baxter International Inc.	Colored esmolol concentrate
GB0818403D0 (en) *	2008-10-08	2008-11-12	Univ Leuven Kath	Aqueous electrophoretic deposition
WO2010040648A2 (fr) *	2008-10-06	2010-04-15	Katholieke Universiteit Leuven, K.U.Leuven R&D	Couches fonctionnelles de biomolécules et de cellules vivantes et nouveau système pour produire celles-ci
CN104224687A (zh) *	2014-09-28	2014-12-24	武汉药谷生物工程有限公司	硝酸异康唑阴道栓及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4368200A (en)	1978-06-23	1983-01-11	Janssen Pharmaceutica N.V.	Heterocyclic derivatives of (4-phenyl-piperazine-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)-methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4267179A (en)	1978-06-23	1981-05-12	Janssen Pharmaceutica, N.V.	Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4490530A (en)	1981-01-14	1984-12-25	Janssen Pharmaceutica N.V.	Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)-methyl-1H-imidazoles and 1H-1,2,4-triazoles
JPS60139688A (ja) *	1983-12-28	1985-07-24	Tokyo Tanabe Co Ltd	無定形ジヒドロピリジン粉末製剤
US4870060A (en)	1985-03-15	1989-09-26	Janssen Pharmaceutica	Derivatives of γ-cylodextrin
GB8506792D0 (en)	1985-03-15	1985-04-17	Janssen Pharmaceutica Nv	Derivatives of y-cyclodextrin
PH30929A (en) *	1992-09-03	1997-12-23	Janssen Pharmaceutica Nv	Beads having a core coated with an antifungal and a polymer.
JPH08509464A (ja)	1993-01-27	1996-10-08	セプラコア，インコーポレイテッド	（２ｒ，４ｓ）イトラコナゾールを使用する方法および組成物
IT1263831B (it)	1993-01-29	1996-09-04	Paolo Chiesi	Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
TW438601B (en) *	1994-05-18	2001-06-07	Janssen Pharmaceutica Nv	New mucoadhesive emulsion compositions and a process for the preparation thereof
FR2722984B1 (fr) *	1994-07-26	1996-10-18	Effik Lab	Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5750147A (en) *	1995-06-07	1998-05-12	Emisphere Technologies, Inc.	Method of solubilizing and encapsulating itraconazole
IL123654A (en)	1995-11-23	2001-08-08	Janssen Pharmaceutica Nv	Process for the preparation of solid mixtures of cyclodextrins and pharmaceutical preparations containing such solid mixtures
US5686133A (en) *	1996-01-31	1997-11-11	Port Systems, L.L.C.	Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
DK0904060T3 (da) *	1996-05-20	2004-04-13	Janssen Pharmaceutica Nv	Antifungale præparater med forbedret biotilgængelighed

1997
- 1997-06-16 KR KR1019970024938A patent/KR19990001564A/ko active Pending
1998
- 1998-06-16 EP EP98929878A patent/EP0991646B1/fr not_active Expired - Lifetime
- 1998-06-16 DK DK98929878T patent/DK0991646T3/da active
- 1998-06-16 BR BR9810124-2A patent/BR9810124A/pt not_active IP Right Cessation
- 1998-06-16 DE DE69805070T patent/DE69805070T2/de not_active Expired - Fee Related
- 1998-06-16 AT AT98929878T patent/ATE216699T1/de not_active IP Right Cessation
- 1998-06-16 HU HU0004050A patent/HUP0004050A3/hu unknown
- 1998-06-16 CN CN98806999A patent/CN1129598C/zh not_active Expired - Fee Related
- 1998-06-16 WO PCT/KR1998/000164 patent/WO1998057967A1/fr not_active Application Discontinuation
- 1998-06-16 AU AU79392/98A patent/AU7939298A/en not_active Abandoned
- 1998-06-16 PT PT98929878T patent/PT991646E/pt unknown
- 1998-06-16 US US09/445,886 patent/US6346533B1/en not_active Expired - Fee Related
- 1998-06-16 YU YU66799A patent/YU66799A/sh unknown
- 1998-06-16 CA CA002294398A patent/CA2294398A1/fr not_active Abandoned
- 1998-06-16 JP JP50419399A patent/JP2002504930A/ja not_active Ceased
- 1998-06-16 ES ES98929878T patent/ES2177022T3/es not_active Expired - Lifetime
- 1998-06-16 PL PL98338631A patent/PL338631A1/xx unknown

Also Published As

Publication number	Publication date
CN1129598C (zh)	2003-12-03
EP0991646B1 (fr)	2002-04-24
WO1998057967A1 (fr)	1998-12-23
BR9810124A (pt)	2000-08-08
ATE216699T1 (de)	2002-05-15
YU66799A (sh)	2002-06-19
DE69805070T2 (de)	2002-11-07
DE69805070D1 (de)	2002-05-29
PL338631A1 (en)	2000-11-06
ES2177022T3 (es)	2002-12-01
HUP0004050A2 (hu)	2001-06-28
CA2294398A1 (fr)	1998-12-23
HUP0004050A3 (en)	2003-03-28
AU7939298A (en)	1999-01-04
CN1262682A (zh)	2000-08-09
PT991646E (pt)	2002-08-30
EP0991646A1 (fr)	2000-04-12
JP2002504930A (ja)	2002-02-12
KR19990001564A (ko)	1999-01-15
US6346533B1 (en)	2002-02-12

Publication	Publication Date	Title
DK0991646T3 (da)	2002-06-10	Itraconazol med forbedret opløselighed, fremgangsmåde til fremstilling deraf, og et farmaceutisk præparat til oral administrering og indeholdende dette
IE894048L (en)	1990-06-22	New therapeutically active compound and a process for its¹preparation
EA199600028A2 (ru)	1996-12-30	Оральная композиция, содержащая s(+)-ибупрофен, и способ ее получения
IL80149A (en)	1990-11-29	Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
AU2766689A (en)	1989-07-20	New pharmaceutical formulations with programmed release
AU2223095A (en)	1995-10-30	Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules
IE64850B1 (en)	1995-09-06	Therapeutically active substituted benzimidazole and process for its preparation
AU5811996A (en)	1996-11-29	Nanoparticles for oral administration of pharmaceutical agen ts of low solubility
CA2180178A1 (fr)	1995-07-06	Utilisation des derives 2,3-diaryl-1-benzopyrane dans la production d'un medicament employe dans le traitement et la prevention de la diminution du volume du tissu osseux et de l'osteoporose
TR200101163T2 (tr)	2001-08-21	Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
IL92799A0 (en)	1990-09-17	Benzimidazole derivatives with gastric acid inhibition and process for its preparation
WO2000048445A3 (fr)	2001-04-26	Composition pharmaceutique contenant de la desoxypeganine utilisee pour le traitement de la dependance a la nicotine
EA200100871A1 (ru)	2002-04-25	Кристаллическая форма эплеренона, обладающая повышенной скоростью растворения
EE03954B1 (et)	2003-02-17	Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
AU3278800A (en)	2000-09-04	Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence
AU2907800A (en)	2000-09-04	Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism
UA66925C2 (uk)	2004-06-15	Поліморфні форми кристалічного цитрату азабіцикло[2.2.2]-октан-3-аміну, спосіб їх одержання, фармацевтична композиція та спосіб лікування блювання
BG106236A (en)	2002-08-30	Melt granulation
BE880648A (fr)	1980-06-17	Nouvelles formes galeniques d'administration de medicaments par voie orale, aliberation programmee et leurs procedes de preparation
IE43848L (en)	1976-12-02	Pharmaceutical compositions
RU93042104A (ru)	1996-05-20	Противокашлевая композиция, содержащая декстрометорфан, способ ее применения
NO964775L (no)	1993-01-27	Fast farmasöytisk adenosinholdig preparat
YU20050410A (sh)	2006-05-25	Kompozicije oksikodona sa kontrolisanim oslobađanjem
JO1653B1 (en)	1991-11-27	The current benzimidazole is a therapeutically active method for preparing it
GT199700078A (es)	1998-12-15	Formulacion de liberacion controlada para farmacos basicos escasamente solubles